-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Evelo Biosciences, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2016 to 2022.
- Evelo Biosciences, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$20.3M, a 29.9% increase year-over-year.
- Evelo Biosciences, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$101M, a 4.66% decline from 2021.
- Evelo Biosciences, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$96.7M, a 32.4% decline from 2020.
- Evelo Biosciences, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2020 was -$73.1M, a 1.51% decline from 2019.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)